title: [Efficacy of combined treatments comprising 6 months' administration of rifampicin in multibacillary leprosy].
abstract: Ten patients infected with mouse proven DDS-resistant bacilli were treated with the following combined regimen: RMP 600 2/7 6 months, ETH 500 7/7 6 months and DDS 100 7/7 12 months. Follow up was for 27-54 months, without relapses. Added to patients from previous study (Int. J. Lepr. 1984, 52, 297-303) the 95% confidence limit decreases from 12 to 9%.
authors.forename: S R
authors.initials: SR
authors.lastname: Pattyn
authors.forename: J A
authors.initials: JA
authors.lastname: Husser
authors.forename: P
authors.initials: P
authors.lastname: Saint-André
mesh_terms: D003622:Dapsone / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005000:Ethionamide / Q000627:therapeutic use*; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D012293:Rifampin / Q000627:therapeutic use*
chemical_list: D003622:Dapsone; D005000:Ethionamide; D012293:Rifampin
vernacular_title: Efficacité de traitements combinés comportant six mois d'administration de rifampicine dans la lèpre multibacillaire.